The FASEB Journal, Vol 11, 498-504, Copyright © 1997 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells

JS Hu, GA Hastings, S Cherry, R Gentz, S Ruben and TA Coleman
Department of Protein Therapeutics, Human Genome Sciences, Inc., Rockville, Maryland 20850, USA.

By high throughput sequencing, we have identified a cDNA encoding a polypeptide related to vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) in the VEGF/PDGF gene family. It is designated vascular endothelial growth factor 2 (VEGF-2). Similar to VEGF, expression of VEGF-2 mRNA is abundant in vascular smooth muscle cells and several highly vascularized tissues. VEGF-2 protein is expressed as a secreted 52 kDa precursor as well as the 30 kDa amino- terminal and 27 kDa carboxy-terminal cleavage products. The latter two cleavage products are linked via a disulfide bridge (or bridges) and can be copurified. Using copurified 30 and 27 kDa proteins, the effect of VEGF-2 on growth of several cell types, including vascular endothelial and smooth muscle cells, was determined. Our results demonstrate that VEGF-2 protein stimulates the growth of human vascular endothelial cells but inhibits growth of human aortic smooth muscle cells induced by platelet-derived growth factor. These studies establish VEGF-2 as a novel regulator for growth of vascular endothelial and smooth muscle cells.

This article has been cited by other articles:

				S. Shah and P. W. Sylvester Tocotrienol-Induced Caspase-8 Activation Is Unrelated to Death Receptor Apoptotic Signaling in Neoplastic Mammary Epithelial Cells Experimental Biology and Medicine, September 1, 2004; 229(8): 745 - 755. [Abstract] [Full Text] [PDF]

				P. A. Yourey, S. Gohari, J. L. Su, and R. F. Alderson Vascular Endothelial Cell Growth Factors Promote the In Vitro Development of Rat Photoreceptor Cells J. Neurosci., September 15, 2000; 20(18): 6781 - 6788. [Abstract] [Full Text] [PDF]

				T. Niki, S. Iba, M. Tokunou, T. Yamada, Y. Matsuno, and S. Hirohashi Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma Clin. Cancer Res., June 1, 2000; 6(6): 2431 - 2439. [Abstract] [Full Text]

				P. CARMELIET and D. COLLEN Molecular Basis of Angiogenesis: Role of VEGF and VE-Cadherin Ann. N.Y. Acad. Sci., May 1, 2000; 902(1): 249 - 264. [Abstract] [Full Text] [PDF]

				T. M. Lau, B. Affandi, and P. A.W. Rogers The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium Mol. Hum. Reprod., January 1, 1999; 5(1): 57 - 63. [Abstract] [Full Text] [PDF]

				B. Witzenbichler, T. Asahara, T. Murohara, M. Silver, I. Spyridopoulos, M. Magner, N. Principe, M. Kearney, J.-S. Hu, and J. M. Isner Vascular Endothelial Growth Factor-C (VEGF-C/VEGF-2) Promotes Angiogenesis in the Setting of Tissue Ischemia Am. J. Pathol., August 1, 1998; 153(2): 381 - 394. [Abstract] [Full Text] [PDF]

				A. Ristimaki, K. Narko, B. Enholm, V. Joukov, and K. Alitalo Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C J. Biol. Chem., April 3, 1998; 273(14): 8413 - 8418. [Abstract] [Full Text] [PDF]

				D. Chilov, E. Kukk, S. Taira, M. Jeltsch, J. Kaukonen, A. Palotie, V. Joukov, and K. Alitalo Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C J. Biol. Chem., October 3, 1997; 272(40): 25176 - 25183. [Abstract] [Full Text] [PDF]